As The Stock Rises By 53.11% Year-To-Date, Oscar Health Inc (NYSE: OSCR)’S Stock Continues To Progress In 2024

During the last session, Oscar Health Inc (NYSE:OSCR)’s traded shares were 1.73 million, with the beta value of the company hitting 1.79. At the end of the trading day, the stock’s price was $14.01, reflecting an intraday gain of 0.57% or $0.08. The 52-week high for the OSCR share is $18.55, that puts it down -32.41 from that peak though still a striking 66.31% gain since the share price plummeted to a 52-week low of $4.72. The company’s market capitalization is $3.22B, and the average intraday trading volume over the past 10 days was 2.36 million shares, and the average trade volume was 3.40 million shares over the past three months.

Oscar Health Inc (NYSE:OSCR) trade information

Oscar Health Inc (OSCR) registered a 0.57% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 0.57% in intraday trading to $14.01, hitting a weekly high. The stock’s 5-day price performance is 0.36%, and it has moved by -8.73% in 30 days. Based on these gigs, the overall price performance for the year is 114.22%. The short interest in Oscar Health Inc (NYSE:OSCR) is 6.31 million shares and it means that shorts have 1.87 day(s) to cover.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Oscar Health Inc (OSCR) estimates and forecasts

Statistics show that Oscar Health Inc has outperformed its competitors in share price, compared to the industry in which it operates. Oscar Health Inc (OSCR) shares have gone up 151.53% during the last six months, with a year-to-date growth rate more than the industry average at 81.15% against 14.20. Yet analysts are ramping up their growth forecast for the fiscal year 2024. Revenue is predicted to grow 250.00% this quarter and then jump 357.10% in the quarter after that. In the rating firms’ projections, revenue will increase 42.20% compared to the previous financial year.

Revenue for the current quarter is expected to be $2.01 billion as predicted by 3 analyst(s). Meanwhile, a consensus of 3 analyst(s) estimates revenue growth to $2.1 billion by the end of Jun 2024. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled $1.15 billion and $1.52 billion respectively. In this case, analysts expect current quarter sales to grow by 75.50% and then jump by 37.80% in the coming quarter.

An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -2.85%. While earnings are projected to return 87.21% in 2024.

OSCR Dividends

Oscar Health Inc is due to release its next quarterly earnings between May 07 and May 13. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

Oscar Health Inc (NYSE:OSCR)’s Major holders

Oscar Health Inc insiders own 1.32% of total outstanding shares while institutional holders control 80.22%, with the float percentage being 81.30%. Alphabet Inc. is the largest shareholder of the company, while 260 institutions own stock in it. As of Jun 29, 2023, the company held over 24.04 million shares (or 12.87% of all shares), a total value of $193.79 million in shares.

The next largest institutional holding, with 12.4 million shares, is of Blackrock Inc.’s that is approximately 6.64% of outstanding shares. At the market price on Jun 29, 2023, these shares were valued at $99.92 million.

Also, the Mutual Funds coming in first place with the largest holdings of Oscar Health Inc (OSCR) shares are Longleaf Partners Small-Cap Fund and Vanguard Total Stock Market Index Fund. Data provided on Jun 29, 2023 indicates that Longleaf Partners Small-Cap Fund owns about 5.91 million shares. This amounts to just over 3.17 percent of the company’s overall shares, with a $47.66 million market value. The same data shows that the other fund manager holds slightly less at 3.94 million, or about 2.11% of the stock, which is worth about $31.73 million.